7 May 2020
At a time when the work of disease modellers has been thrust into the spotlight, DPUK’s director, Professor John Gallacher, comments on the important role of technology platforms which democratise access to global health data.
15 April 2019
One in three people born today will develop dementia in their lifetime: it's the biggest health challenge of our generation. With one million people predicted to have dementia by 2025 in the UK, and a current cost of £26bn a year to the UK economy, there is huge financial and societal impact, yet we’re still without treatment.
General Impact Research Trials
8 February 2019
DPUK has launched Great Minds, an innovative new register of volunteers for clinical trials who bring rich data from their previous health studies to help clear the deadlock in development of treatments for dementia.
24 October 2018
Data scientists from many different backgrounds combined their expertise to take on dementia in an unusual format for disease research: a three-day datathon. The intensive research event saw teams come together to work on data that is now available in the DPUK Data Portal.
1 October 2018
Thanks to leaps forward in computing power, DPUK is able to harness highly advanced technical solutions to maintain data security and non-identifiability of millions of existing health records in the Data Portal. It’s a model that is globally unique for dementia research and one that’s increasingly attracting attention from other sectors.
21 September 2018
Thanks to the generosity of two million health studies volunteers, there is new hope for accelerating the discovery of treatments for dementia. Their combined data – lifestyle, genes, memory tests, and brain scans – are helping researchers identify changes over time which will reveal how dementia starts in healthy brains.
28 June 2018
Dementias Platform UK continues to expand as Cambridge Cognition, a global leader in cognitive assessment for clinical trials, upgrades its current position as associate partner to become full partner.
General Publication Research
4 May 2018
Body-worn sensors used by people with mild Alzheimer’s to assess walking could offer a cost-effective way to detect the disease early and monitor its progression.